End-of-day quote
Thailand S.E.
06:00:00 2024-05-02 pm EDT
|
5-day change
|
1st Jan Change
|
251
THB
|
+3.29%
|
|
+1.21%
|
+13.06%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
107,140
|
95,350
|
112,037
|
168,516
|
176,465
|
199,524
|
-
|
-
|
Enterprise Value (EV)
1 |
101,162
|
89,820
|
106,195
|
160,303
|
165,810
|
186,510
|
185,717
|
182,639
|
P/E ratio
|
34
x
|
86.3
x
|
101
x
|
37.3
x
|
27.5
x
|
27.3
x
|
25.8
x
|
25.2
x
|
Yield
|
2.18%
|
2.67%
|
2.27%
|
1.65%
|
2.03%
|
1.95%
|
2.18%
|
2.3%
|
Capitalization / Revenue
|
5.72
x
|
7.66
x
|
8.99
x
|
8.13
x
|
6.95
x
|
7.33
x
|
6.81
x
|
6.39
x
|
EV / Revenue
|
5.4
x
|
7.22
x
|
8.52
x
|
7.74
x
|
6.53
x
|
6.85
x
|
6.34
x
|
5.85
x
|
EV / EBITDA
|
17.2
x
|
34.7
x
|
40.6
x
|
23.1
x
|
17.6
x
|
17.9
x
|
16.8
x
|
16
x
|
EV / FCF
|
32.2
x
|
65.6
x
|
38.6
x
|
31.6
x
|
30
x
|
25.2
x
|
27.1
x
|
24.1
x
|
FCF Yield
|
3.11%
|
1.52%
|
2.59%
|
3.16%
|
3.33%
|
3.96%
|
3.69%
|
4.15%
|
Price to Book
|
5.36
x
|
5.15
x
|
6.48
x
|
8.55
x
|
7.41
x
|
7.36
x
|
6.48
x
|
5.85
x
|
Nbr of stocks (in thousands)
|
728,841
|
794,586
|
794,586
|
794,886
|
794,886
|
794,916
|
-
|
-
|
Reference price
2 |
147.0
|
120.0
|
141.0
|
212.0
|
222.0
|
251.0
|
251.0
|
251.0
|
Announcement Date
|
2/26/20
|
2/18/21
|
2/24/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
18,718
|
12,445
|
12,460
|
20,721
|
25,376
|
27,232
|
29,279
|
31,205
|
EBITDA
1 |
5,884
|
2,591
|
2,613
|
6,940
|
9,398
|
10,424
|
11,034
|
11,434
|
EBIT
1 |
4,661
|
1,371
|
1,434
|
5,823
|
8,301
|
9,153
|
9,683
|
10,038
|
Operating Margin
|
24.9%
|
11.01%
|
11.5%
|
28.1%
|
32.71%
|
33.61%
|
33.07%
|
32.17%
|
Earnings before Tax (EBT)
1 |
4,534
|
1,243
|
1,456
|
6,049
|
8,638
|
9,314
|
9,907
|
9,970
|
Net income
1 |
3,748
|
1,204
|
1,216
|
4,938
|
7,006
|
7,538
|
8,035
|
8,151
|
Net margin
|
20.02%
|
9.68%
|
9.76%
|
23.83%
|
27.61%
|
27.68%
|
27.44%
|
26.12%
|
EPS
2 |
4.320
|
1.390
|
1.400
|
5.690
|
8.080
|
9.206
|
9.739
|
9.972
|
Free Cash Flow
1 |
3,143
|
1,370
|
2,753
|
5,067
|
5,522
|
7,393
|
6,845
|
7,589
|
FCF margin
|
16.79%
|
11%
|
22.09%
|
24.45%
|
21.76%
|
27.15%
|
23.38%
|
24.32%
|
FCF Conversion (EBITDA)
|
53.41%
|
52.86%
|
105.34%
|
73%
|
58.76%
|
70.92%
|
62.04%
|
66.37%
|
FCF Conversion (Net income)
|
83.85%
|
113.73%
|
226.46%
|
102.6%
|
78.82%
|
98.07%
|
85.19%
|
93.09%
|
Dividend per Share
2 |
3.200
|
3.200
|
3.200
|
3.500
|
4.500
|
4.906
|
5.484
|
5.761
|
Announcement Date
|
2/26/20
|
2/18/21
|
2/24/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
-
|
6,667
|
5,694
|
3,938
|
4,118
|
4,922
|
-
|
5,693
|
5,988
|
6,069
|
6,049
|
12,119
|
6,775
|
6,516
|
6,537
|
6,387
|
7,637
|
7,230
|
7,030
|
-
|
EBITDA
|
-
|
1,632
|
988.5
|
966.6
|
1,181
|
1,701
|
-
|
2,120
|
2,089
|
2,200
|
2,296
|
4,477
|
2,608
|
2,318
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
-
|
-
|
660.5
|
904.5
|
1,395
|
-
|
1,842
|
1,805
|
1,925
|
2,021
|
3,927
|
2,336
|
2,044
|
2,409
|
2,150
|
2,600
|
2,177
|
2,340
|
-
|
Operating Margin
|
-
|
-
|
-
|
16.77%
|
21.96%
|
28.34%
|
-
|
32.35%
|
30.15%
|
31.71%
|
33.41%
|
32.41%
|
34.48%
|
31.37%
|
36.86%
|
33.66%
|
34.04%
|
30.11%
|
33.28%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
358
|
755.8
|
903
|
1,430
|
-
|
1,821
|
1,889
|
1,949
|
2,148
|
4,097
|
2,401
|
2,140
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
809.6
|
307.6
|
612.1
|
725
|
1,166
|
1,891
|
1,501
|
1,546
|
1,583
|
1,748
|
3,331
|
1,954
|
1,721
|
1,985
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
12.14%
|
5.4%
|
15.54%
|
17.61%
|
23.69%
|
-
|
26.37%
|
25.82%
|
26.09%
|
28.89%
|
27.49%
|
28.85%
|
26.41%
|
30.37%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
0.3500
|
0.7000
|
0.8400
|
1.340
|
-
|
1.730
|
1.780
|
1.830
|
2.010
|
3.840
|
2.250
|
1.990
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
2.050
|
-
|
-
|
2.050
|
-
|
1.150
|
1.150
|
-
|
2.350
|
-
|
-
|
-
|
1.370
|
3.150
|
-
|
1.449
|
1.449
|
1.449
|
1.762
|
1.762
|
Announcement Date
|
2/26/20
|
8/5/20
|
8/12/21
|
2/24/22
|
4/28/22
|
8/10/22
|
8/10/22
|
11/9/22
|
2/16/23
|
4/27/23
|
8/10/23
|
8/10/23
|
11/9/23
|
2/22/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
5,977
|
5,530
|
5,841
|
8,213
|
10,654
|
13,013
|
13,807
|
16,885
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
3,143
|
1,370
|
2,753
|
5,067
|
5,522
|
7,393
|
6,845
|
7,589
|
ROE (net income / shareholders' equity)
|
19.5%
|
6.25%
|
6.79%
|
26.7%
|
31.8%
|
29.7%
|
27.6%
|
25.3%
|
ROA (Net income/ Total Assets)
|
14.7%
|
4.78%
|
5.39%
|
21.9%
|
26.2%
|
24.6%
|
23.7%
|
21.8%
|
Assets
1 |
25,465
|
25,191
|
22,539
|
22,558
|
26,742
|
30,701
|
33,913
|
37,440
|
Book Value Per Share
2 |
27.40
|
23.30
|
21.80
|
24.80
|
29.90
|
34.10
|
38.70
|
42.90
|
Cash Flow per Share
2 |
5.650
|
2.600
|
4.100
|
7.160
|
8.180
|
10.80
|
11.60
|
11.50
|
Capex
1 |
1,755
|
888
|
803
|
1,146
|
1,572
|
2,330
|
2,432
|
1,491
|
Capex / Sales
|
9.37%
|
7.14%
|
6.44%
|
5.53%
|
6.2%
|
8.56%
|
8.3%
|
4.78%
|
Announcement Date
|
2/26/20
|
2/18/21
|
2/24/22
|
2/16/23
|
2/22/24
|
-
|
-
|
-
|
Average target price
289.8
THB Spread / Average Target +15.45% Consensus |
1st Jan change
|
Capi.
|
---|
| +13.06% | 5.42B | | +13.70% | 80.61B | | -29.20% | 70.18B | | +9.86% | 29.12B | | -11.43% | 16.97B | | -0.68% | 16.96B | | -0.31% | 15.26B | | +2.87% | 12.41B | | -31.05% | 11.95B | | -6.75% | 11.93B |
Other Healthcare Facilities & Services
|